China Pharma Holdings (CPHI) EPS (Basic) (2011 - 2026)
China Pharma Holdings' (CPHI) quarterly EPS (Basic) came in at -$0.04 in Q2 2026, up 77.78% on a YoY basis from -$0.02 in Q2 2025, and up 19.41% quarter-over-quarter from -$0.04 in Q1 2026.
Powered by 
Analysis
China Pharma Holdings (CPHI) EPS (Basic) (2011 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has reported EPS (Basic) for 16 consecutive years, with -$0.04 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 77.78% year-over-year to -$0.04; the trailing twelve-month figure through Jun 2026 stood at -$0.11 (up 90.15% YoY), and the FY2025 full-year result was -$0.56, up 72.61% from the prior year.
- EPS (Basic) advanced to -$0.04 in Q2 2026 per CPHI's latest filing, from -$0.04 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.04 in Q2 2026 and bottomed at -$12.02 in Q4 2022.
- Historically, EPS (Basic) has averaged -$3.13 across 5 years, with a median of -$0.81 in 2024.
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) fell 29.1% in 2022, then soared 81.84% in 2025.
- Over 5 years, EPS (Basic) stood at -$12.02 in 2022, then surged by 69.71% to -$3.64 in 2023, then soared by 80.75% to -$0.7 in 2024, then surged by 59.38% to -$0.28 in 2025, then jumped by 87.36% to -$0.04 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.04, -$0.04, and -$0.28 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 1.68 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -3.06 |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 2.92 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 7.82 |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 | -0.04 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.04 |
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.28 |
| Sep 30, 2025 | -0.17 |
| Jun 30, 2025 | -0.16 |
| Mar 31, 2025 | -0.24 |
| Dec 31, 2024 | -0.70 |
| Sep 30, 2024 | -0.65 |
| Jun 30, 2024 | -0.89 |
| Mar 31, 2024 | -0.73 |
| Dec 31, 2023 | -3.64 |
| Sep 30, 2023 | -2.94 |
| Jun 30, 2023 | -2.99 |
| Mar 31, 2023 | -2.95 |
| Dec 31, 2022 | -12.02 |
| Sep 30, 2022 | -7.91 |
| Jun 30, 2022 | -9.16 |
| Mar 31, 2022 | -10.87 |
| Dec 31, 2021 | -10.63 |
| Sep 30, 2021 | -8.99 |